Dokument

Zusammenfassung:
Es werden die Ergebnisse nach subretinaler Chirurgie bei Patienten mit feuchter altersbedingter Makuladegeneration beschrieben.

Bibliographie / References

1. Meyers S.M.; Greene T.; Gutman F.A.: A twin study of age-related macular de- generation; American Journal of Ophthalmology 120 (1995)
2. Giudice G.; De Belvis V.; Piermarocchi S.; Galan A.; Prosdocimo G.: Acute visual loss and chorioretinal infarction after photodynamic therapy combined with intravitreal triamcinolone; European Journal of Ophthalmology 18 (2008) 55 Lommatzsch A.; Spital G.; Trieschmann M.; Pauleikhoff D.: Intraokulare Injek- tion von Bevacizumab; Ophthalmologe 104 (2007)
3. Thumann G.; Aisenbrey S.; Schraermeyer U.; Lafaut B.; Esser P.; Walter P.; Bartz-Schmidt K.U.: Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes; Archives of Ophthalmology 118 (2000)
4. Schmidt-Erfurt U.; Miller J.; Sickenberg M.; Bunse A.; Laqua H.; Gragoudas E.; Zografos L.; Birngruber R.; van den Bergh H.; Strong A.; Manjuris U.; Fsadni M.; Lane A.M.; Piguet B.; Bressler N.M.: Photodynamic therapy of subfoveal choroi- dal neovascularization: clinical and angiographic examples.: Graefe´s archive for clinical and experimental Ophthalmology 236 (1998)
5. Toth C.A.; Benner J.D.; Hjelmeland L.M.; Landers M.B. 3 rd .; Morse L.S.: Ultra- microsurgical removal of subretinal hemorrhage in cats.; American Journal of Ophthalmology 113 (1992)
6. Holz F.G.; Pauleikhoff D.; Spaide R.F.; Bird A.C.: Altersabhängige Makuladege- neration; Springer Verlag, 2. Auflage (2004); Berlin, Heidelberg, New York 42 Holz F.G.; Kirchhof B.: Prävention der altersabhängigen Makuladegeneration; Ophthalmologe 98 (2001)
7. Schmidt J.C.; Rodrigues E.B.; Meyer C.H.; Hoerle S.; Kroll P.: A modified tech- nique to stain the internal limiting membrane with indocyanine green; Ophthal- mologica 218 (2004)
8. Vedula S.; Krzystolik M.: Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration; Coch- rane database of systematic reviews 16 (2008)
9. Schiebler Schmidt.: Anatomie; Springer Verlag, 8. Auflage (2002); Berlin, Hei- delberg, New York 86 Schmidt-Erfurth U.; Hasan T.; Gragoudas E.; Michaud N.; Flotte T.J.; Birngruber R.: Vascular targeting in photodynamic occlusion of subretinal vessels.; Ophthal- mology 101 (1994)
10. Mackensen G.; Neubauer H.: Augenärztliche Operationen 2.; Springer-Verlag, 1988; Berlin, Heidelberg, New York, London, Paris, Tokyo 59 Majji A.B.; de Juan E. Jr.: Retinal pigment epithelial autotransplantation: morpho- logical changes in retina and choroid;Graefès archive for clinical and experimen- tal Ophthalmology 238 (2000)
11. Straub W.; Kroll P.; Küchle H.J.: Augenärztliche Untersuchungsmethoden; Ferdi- nand Enke Verlag, 2. Auflage (1995); Stuttgart
12. Heussen F.M.; Fawzy N.F.; Joeres S.; Lux A.; Maaijwee K.; Meurs J.C.; Kirchhof B.; Joussen A.M.: Autologous translocation of the choroid and RPE in age-related macular degeneration: 1-year follow-up in 30 patients and recommendations for patient selection; Eye 22 (2008)
13. Rosenfeld P.J.; Brown D.M.; Heier J.S.; Boyer D.S.; Kaiser P.K.; Chung C.Y.; Kim R.Y.: Bevacizumab vs Ranibizumab treatment for age-related macular de- generation; Archives of Ophthalmology 125 (2007)
14. Rezai K.A.; Lappas A.; Kohen L.; Wiedemann P.; Heimann K.: Comparison of tight junction permeability for albumin in iris pigment epithelium and retinal pig- ment epithelium in vitro;Graefès archive for clinical and experimental Ophthal- mology 235 (1997)
15. Thumann G.: Development and cellular functions of the iris pigment epithelium; Survey of Ophthalmology 45 (2001)
16. Holz F.G.; Pauleikhoff D.: Die altersabhängige Makuladegeneration. 2. Therapeu- tische Ansätze; Ophthalmologe 93 (1996)
17. Miller D.W.; Joussen A.M.; Holz F.G.: Die molekularen Mechanismen der neo- vaskulären AMD; Ophthalmologe 100 (2003)
18. Pauleikhoff D.; Barondes M.J.; Minassian D.; Chisholm I.H.; Bird A.C.: Drusen as risk factors in age-related macular disease; American Journal of Ophthalmol- ogy 109 (1990)
19. Metelitsina T.I.; Grunwald J.E.; DuPont J.C.; Ying G-S.; Brucker A.J.; Dunaief J.L.: Foveolar choroidal circulation and choroidal neovascularisation in age- related Macular Degeneration; Investigative Ophthalmology & Visual Science 49 (2008)
20. Klein R.; Knudtson M.D.; Cruickshanks K.J.; Klein B.E.K.: Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration; Archives of Ophthalmology 126 (2008)
21. Tasman W.: History of Retina 1896-1996; Ophthalmology 103 (1996) 101
22. Ohji M.; Fujikado T.; Kusaka S.; Hayashi A.; Hosohata J.; Ikuno Y.; Sawa M.; Kubota A.; Hashida N.; Tano Y.: Comparison of three techniques of foveal trans- location in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration.; American Journal of Ophthalmology 132 (2001)
23. Maaijwee K.; Missotten T.; Mulder P.; van Meurs J.C.: Influence of intraopera- tivecourse on visual outcome after an RPE-choroid Translocation; Investigative Ophthalmology & Visual Science 49 (2008)
24. Weigert G.; Michels S.; Sacu S.; Varga A.; Prager F.; Geitzenauer W.; Schmidt- Erfurth U.: Intravitreal bevacizumab (Avastin) therapy versus photodynamic theapy plus Intravitreal triamcinolone for neovascular age-related macular degen- eration: 6-month results of a prospective, randomised, controlled clinical study; British Journal of Ophthalmology 92 (2008)
25. Lappas A.; Weinberger A.W.; Foerster A.M.; Kube T.; Rezai K.A.; Kirchhof B.: Iris pigment epithelial cell translocation in exudative age-related macular degen- eration. A pilot study in patients.; Graefe´s archive for clinical and experimental ophthalmology 238 (2000)
26. Schmidt J.C.; Rodrigues E.B.; Meyer C.H.; Kroll P.: Is membrane extraction in cases of exudative age-related macular degeneration still up-to-date?; Ophthal- mologica 217 (2003)
27. Sawa M.; Gomi F.; Tsujikawa M.; Sakaguchi H.; Tano Y.: Long-terms results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks; American Journal of Ophthalmology 148 (2009)
28. Toth C.A.; Freedman S.F.: Macular translocation with 360-degree peripheral reti- nectomy impact of technique and surgical experience on visual outcomes.; Retina 21 (2001)
29. Schmidt J.C.: Makulachirurgie 2005-quo vadis?; Ophthalmologische Nachrichten m08/2005
30. Schmidt J.C.; Meyer C.H.; Mennel S.; Hörle S.: Makulatransposition als Thera- pieoption bei subfovealer Neovaskularisation; Spektrum der Augenheilkunde 18 (2004)
31. Pauleikhoff D.; van Kuijk F.J.; Bird A.C.: Makuläres Pigment und altersabhängi- ge Makuladegeneration; Ophthalmologe 98 (2001)
32. Neuner B.; Wellmann J.; Dasch B.; Behrens T.; Claes B.; Dietzel M.; Pauleikhoff D.; Hense H.W.: Modeling smoking history: a comparison of different approaches in the MARS study on age-related maculopathy; Annals of epidemiology 17 (2007)
33. Pauleikhoff D.: Neovascular age-related macular degeneration. Natural history and treatment outcomes; Retina, The journal of retinal and vitreous diseases 25 (2005)
34. Holz F.G.: Neue Therapieansätze für die altersabhängige Makuladegeneration; Ophthalmologe 100 (2003)
35. Schachat A.P.: New treatments for age-related macular degeneration; Ophthal- mology 112 (2005)
36. Stur M.; Tittl M.; Reitner A.; Meisinger V.: Oral zinc and the second eye in age- related macular degeneration.; Investigative ophthalmology & visual science 37 (1996)
37. Newsome D.A.; Swartz M.; Leone N.C.; Elston R.C.; Miller E.: Oral zinc in macular degeneration.; Archives of Ophthalmology 106 (1988)
38. Schmidt J.C.; Meyer C.H.; Mennel S.: Pars-plana vitrectomy with anterior cham- ber infusion via a paracentesis in pseudophakic eyes; Ophthalmologe 104 (2007) 95 Schraermeyer U.; Kayatz P.; Thumann G.; Luther TT.; Szurman P.; Kociok N.; Bartz-Schmidt K.U.: Transplantation of iris pigment epithelium into the choroid slows down the degeneration of photoreceptors in the RCS rat; Graefe´s archive for clinical and experimental Ophthalmology 238 (2000)
39. Herzlich A.A.; Tuo J.; Chan C.C.: Peroxisome proliferator-activated receptor and age-related macular degeneration; PPAR Research (2008)
40. Thumann G.; Bartz-Schmidt K.U.; Heimann K.; Schraermeyer U.: Phagocytosis of rod outer segments by human iris pigment epithelial cells in vitro; Graefe´s ar- chive for clinical and experimental Ophthalmology 236 (1998)
41. Holz F.G.; Miller D.W.: Pharmakologische Therapie der altersabhängigen Maku- ladegeneration; Ophthalmologe 100 (2003)
42. Miller J.W.; Walsh A.W.; Kramer M.; Hasan T.; Michaud N.; Flotte T.J.; Haimo- vici R.; Gragoudas E.S.: Photodynamic Therapy of Experimental Choroidal Neo- vascularization Using Lipoprotein-Delivered Benzoporphyrin; Archives of Ophthalmology 113 (1995)
43. Schmidt-Erfurth Ursula MD.; Joan W. Miller MD.; Michel Sickenberg MD.; Horst Laqua MD.; Irene Barbazetto MD.; Evangelos S. Gragoudas MD.; Leonidas Zografos MD.; Bertrand Piguet MD.; Constantin J. Pournaras MD.; Guy Donati MD.; Anne-Marie Lane MPH.; Reginald Birngruber PhD.; Hubert van den Berg PhD.; H. Andrew Strong PhD.; Ulrike Manjuris PhD.; Todd Gray MSPH.; Mario Fsadni MRCOphth.; Neil M. Bressler MD.: Photodynamic Therapy With Verte- porfin for Choroidal Neovaskularisation Caused by Age-related Macular Degen- eration; Archives of Ophthalmology 117 (1999)
44. Hörle S.; Pöstgens H.; Schmidt J.; Kroll P.: Pigment epithelium defects after sub- macular surgery for choroidal neovascularisation: First results; Ophthalmologica 214 (2000)
45. Potter M.J.; Szabo S.M.: Recurrence of choroidal neovascularisation after photo- dynamic therapy in patients with age-related macular degeneration; British Jour- nal of Ophthalmology 91 (2007) 77 Pschyrembel: Klinisches Wörterbuch, 258. Auflage (1998); Berlin, New York 78 Rehak M.; Fric E.; Wiedemann P.: Lutein and antioxidants in the prevention of age-related macular degeneration; Ophthalmologe 105 (2008)
46. Slusher M.M.; O´Steen W.K.: Release of scientific information to the news me- dia.; Archives of Ophthalmology 107 (1989)
47. Treister G.; Machemer R.: Results of vitrectomy for rare proliferative and hemor- rhagic diseases.; American Journal of Ophthalmology 84 (1977)
48. Machemer R.; Steinhorst U.H.: Retinal separation, retinotomy, and macular relo- cation: 2. A surgical approach for age-related macular degeneration?; Graefe´s ar- chive for clinical and experimental Ophthalmology 231 (1993)
49. Müller-Velten R.; Michels St.; Schmidt-Erfurth U.; Laqua H.: Photodynamische Therapie: erweiterte Indikationen; Ophthalmologe 100 (2003)
50. Wade E.C.; Flynn H.W. Jr.; Olsen K.R.; Blumenkranz M.S.; Nicholson D.H.: Subretinal hemorrhage management by pars plana vitrectomy and internal drain- age; Archives of Ophthalmology 108 (1990)
51. Lambert H.M.; Capone A Jr.; Aaberg T.M.; Sternberg P Jr.; Mandell B.A.; Lopez P.F.: Surgical excision of subfoveal neovascular membranes in age-related macu- lar degeneration.; American Journal of Ophthalmology 113 (1992)
52. Thomas M.A.; Grand M.G.; Williams D.F.; Lee C.M.; Pesin S.R.; Lowe M.A.: Surgical management of subfoveal choroidal neovascularization.; Ophthalmology 99 (1992)
53. Mandelcorn M.S.; Menezes A.V.: Surgical removal of subretinal hemorrhage and choroidal neovascular membranes in acute hemorrhagic age-related macular de- generation.; Canadian Journal of Ophthalmology. Journal canadien d´ophtalmologie 28 (1993)
54. Kociok N.; Heppekausen H.; Schraermeyer U.; Esser P.; Thumann G.; Grisanti S.; Heimann K.: The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells; Experimental eye research 67 (1998)
55. Lewis H.; VanderBrug Medendorp S.: Tissue plasminogen activator-assisted sur- gical excision of subfoveal choroidal neovascularization in age-related macular degeneration: a randomized, double-masked trial.; Ophthalmology 104 (1997) 53
56. Pedersen R.; Soliman W.; Lund-Andersen H.; Larsen M.: Treatment of choroidal neovascularisation using intravitreal bevacizumab; Acta Ophthalmologica Scan- dinavica 85 (2007)
57. Michels S.; Rosenfeld P.J.: Treatment of neovascular age-related macular degen- eration with Ranibizumab/Lucentis; Klinische Monatsblätter für Augenheilkunde 222 (2005)
58. Lindsey P.S.; Michels R.G.; Luckenbach M.; Green W.R.: Ultrastructure of epiretinal membrane causing retinal starfold.; Ophthalmology 90 (1983)
59. Schmidt J.C.; Mennel S.; Hörle S.; Meyer C.H.: High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy; British Journal of Ophthalmology 90 (2006)
60. Rudolf M.; Clark M.E.; Chimento M.F.; Li C.M.; Medeiros N.E.; Curcio C.A.: Prevalence and Morphology of Druse Types in the Macula and Periphery of Eyes with Age-Related Maculopathy; Investigative Ophthalmology & Visual Science 49 (2008) 82 Sachsenweger Matthias.: MLP Duale Reihe, Augenheilkunde; Hippokrates- Verlag, 1993; Stuttgart
61. Hudson H.L.; Frambach D.A.; Lopez P.F.: Relation of the functional and struc- tural fundus changes after submacular surgery for neovascular age-related macular degeneration.; The British Journal of Ophthalmology 79 (1995)

Das Dokument ist im Internet frei zugänglich - Hinweise zu den Nutzungsrechten